Strand-specific in vivo screen of cancer-associated miRNAs unveils a role for miR-21-in SCC progression

Nature Cell Biology

Volumn 18, Issue 1, 2016, Pages 111-121

  Ge, Yejing ^a   Zhang, Liang ^a,c,d,e   Nikolova, Maria ^a   Reva, Boris ^b   Fuchs, Elaine ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

^e Collaborative Innovation Center of Systems Biomedicine ^*  (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MIR 21; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG; MIRN21 MICRORNA, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER PROGNOSIS; CANCER STEM CELL; CARCINOGENICITY; CELL CYCLE; CONTROLLED STUDY; GENE; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MOUSE; NONHUMAN; PHACTR4 GENE; PRIORITY JOURNAL; RNA STRUCTURE; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; ANIMAL; CELL PROLIFERATION; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; TUMOR CELL LINE;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; MICE; MICRORNAS;

EID: 84952637959     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb3275     Document Type: Article

References (39)

1. Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell. 136, 215-233 (2009).
2. Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature. 435, 834-838 (2005).
3. Lujambio, A., Lowe, S. W. The microcosmos of cancer. Nature. 482, 347-355 (2012).
4. Di Leva, G., Garofalo, M., Croce, C. M. MicroRNAs in cancer. Annu. Rev. Pathol. 9, 287-314 (2014).
5. Adams, B. D., Kasinski, A. L., Slack, F. J. Aberrant regulation and function of MicroRNAs in cancer. Curr. Biol. 24, R762-R776 (2014).
6. Darido, C. et al. Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis. Cancer Cell 20, 635-648 (2011).
7. Ma, X. et al. Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis. Proc. Natl Acad. Sci. USA 108, 10144-10149 (2011).
8. Bhandari, A. et al. The Grainyhead transcription factor Grhl3/Get1 suppresses miR-21 expression and tumorigenesis in skin: modulation of the miR-21 target MSH2 by RNA-binding protein DND1. Oncogene 32, 1497-1507 (2013).
9. Benaich, N. et al. Rewiring of an epithelial differentiation factor, miR-203, to inhibit human squamous cell carcinoma metastasis. Cell Rep. 9, 104-117 (2014).
10. Zhang, L., Ge, Y., Fuchs, E. miR-125b can enhance skin tumor initiation and promote malignant progression by repressing differentiation and prolonging cell survival. Genes Dev. 28, 2532-2546 (2014).
11. Schober, M., Fuchs, E. Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-and integrin/focal adhesion kinase (FAK) signaling. Proc. Natl Acad. Sci. USA 108, 10544-10549 (2011).
12. Lapouge, G. et al. Skin squamous cell carcinoma propagating cells increase with tumour progression and invasiveness. Embo J. 31, 4563-4575 (2012).
13. Oshimori, N., Oristian, D., Fuchs, E. TGF-promotes heterogeneity and drug resistance in squamous cell carcinoma. Cell 160, 963-976 (2015).
14. Anders, S., Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).
15. Adam, R. C. et al. Pioneer factors govern super-enhancer dynamics in stem cell plasticity and lineage choice. Nature 521, 366-370 (2015).
16. Beronja, S., Livshits, G., Williams, S., Fuchs, E. Rapid functional dissection of genetic networks via tissue-specific transduction and RNAi in mouse embryos. Nat. Med. 16, 821-827 (2010).
17. Beronja, S. et al. RNAi screens in mice identify physiological regulators of oncogenic growth. Nature 501, 185-190 (2013).
18. Schramek, D. et al. Direct in vivo RNAi screen unveils myosin IIa as a tumor suppressor of squamous cell carcinomas. Science 343, 309-313 (2014).
19. Quintanilla, M., Brown, K., Ramsden, M., Balmain, A. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 322, 78-80 (1986).
20. Nassar, D., Latil, M., Boeckx, B., Lambrechts, D., Blanpain, C. Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma. Nat. Med. 21, 946-954 (2015).
21. Ma, L., Teruya-Feldstein, J., Weinberg, R. A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 449, 682-688 (2007).
22. Gregory, P. A. et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10, 593-601 (2008).
23. Taylor, M. A., Sossey-Alaoui, K., Thompson, C. L., Danielpour, D., Schiemann, W. P. TGF-upregulates miR-181a expression to promote breast cancer metastasis. J. Clin. Invest. 123, 150-163 (2013).
24. Chen, X. et al. Endogenous expression of Hras(G12V) induces developmental defects and neoplasms with copy number imbalances of the oncogene. Proc. Natl Acad. Sci. USA 106, 7979-7984 (2009).
25. Hatley, M. E. et al. Modulation of K-Ras-dependent lung tumorigenesis by microRNA-21. Cancer Cell 18, 282-293 (2010).
26. Medina, P. P., Nolde, M., Slack, F. J. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467, 86-90 (2010).
27. Fujita, S. et al. miR-21 gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J. Mol. Biol. 378, 492-504 (2008).
28. Talotta, F. et al. An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation. Oncogene 28, 73-84 (2009).
29. Sanjana, N. E., Shalem, O., Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783-784 (2014).
30. John, B. et al. Human MicroRNA targets. PLoS Biol. 2, e363 (2004).
31. Lewis, B. P., Burge, C. B., Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20 (2005).
32. Frankel, L. B. et al. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem. 283, 1026-1033 (2008).
33. Solimini, N. L. et al. STOP gene Phactr4 is a tumor suppressor. Proc. Natl Acad. Sci. USA 110, E407-414 (2013).
34. Kim, T. H., Goodman, J., Anderson, K. V., Niswander, L. Phactr4 regulates neural tube and optic fissure closure by controlling PP1-, Rb-, and E2F1-regulated cell-cycle progression. Dev Cell. 13, 87-102 (2007).
35. Pink, R. C. et al. The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells. Gynecol. Oncol. 137, 143-151 (2015).
36. Yi, R. et al. Morphogenesis in skin is governed by discrete sets of differentially expressed microRNAs. Nat. Genet. 38, 356-362 (2006).
37. Li, H., Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009).
38. Ge, Y., Sun, Y., Chen, J. IGF-II is regulated by microRNA-125b in skeletal myogenesis. J. Cell Biol. 192, 69-81 (2011).
39. Keyes, B. E. et al. Nfatc1 orchestrates aging in hair follicle stem cells. Proc. Natl Acad. Sci. USA 110, E4950-E4959 (2013).